News & Media

Keeping our Media Partners in the Loop

27 January 2026

Pharmascience Canada introduces the launch of ᵖʳpms-SACUBITRIL-VALSARTAN

Read the article

4 December 2025

Pharmascience climbs the ranks of Canada’s Top 100 Corporate R&D Investors!

Read the article

19 November 2025

Pharmascience Announces the Appointment of Jim Vounassis as Chief Executive Officer

Read the article

7 November 2025

Federal Budget 2025: A Lever for Pharmaceutical Resilience, Productivity, and Canadian Innovation

Read the article

5 March 2025

Pharmascience Canada expands its portfolio with a treatment for Parkinson’s disease patients

Read the article

6 February 2025

Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment

Read the article

1 2 3 4 5 6 7 8 9 … 13

Media Relations

Please send us an email and provide us with your contact information as well as the name of your media/publication/source. A member of our team will contact you back quickly.

Topics

All Award/Recognition Business News Buying Locally COVID Employer Awards Our Divisions Product Launches Public Stance

About Pharmascience

Since 1983, Pharmascience has been a leading Canadian manufacturer of generic, branded, and over-the-counter pharmaceuticals, serving both domestic and international markets.

About Us

Professional Services Portal (Canada)

Healthcare Professional Authentication or Access? (Canada)

Keeping our Media Partners in the Loop

Pharmascience Canada introduces the launch of ᵖʳpms-SACUBITRIL-VALSARTAN

Pharmascience climbs the ranks of Canada’s Top 100 Corporate R&D Investors!

Pharmascience Announces the Appointment of Jim Vounassis as Chief Executive Officer

Federal Budget 2025: A Lever for Pharmaceutical Resilience, Productivity, and Canadian Innovation

Pharmascience Canada expands its portfolio with a treatment for Parkinson’s disease patients

Pharmascience Canada strengthens its commitment to patients with an antihistamine treatment